An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive results. Results ...
Noninvasive imaging biomarkers for survival risk stratification with tarlatamab in ES-SCLC. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This abstract does not include a full ...
A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS 2025 International Conference, and in American ...
Identification and validation of arsenic-associated genes and risk model for predicting lung cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...
An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive results. Results ...
The surveillance protocol for early-stage non–small cell lung cancer (NSCLC) is not contingent upon individualized risk factors for recurrence. This study aimed to use comprehensive data from clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results